- Home
- XPEL vs VALN Comparison
XPEL vs VALN Comparison
Compare XPEL & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEL
- VALN
- Stock Information
- Founded
- XPEL 1999
- VALN 2012
- Country
- XPEL United States
- VALN France
- Employees
- XPEL N/A
- VALN 713
- Industry
- XPEL Industrial Specialties
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XPEL Industrials
- VALN Health Care
- Exchange
- XPEL Nasdaq
- VALN Nasdaq
- Market Cap
- XPEL 984.3M
- VALN 777.9M
- IPO Year
- XPEL N/A
- VALN 2021
- Fundamental
- Price
- XPEL $35.91
- VALN $9.15
- Analyst Decision
- XPEL
- VALN Strong Buy
- Analyst Count
- XPEL 0
- VALN 4
- Target Price
- XPEL N/A
- VALN $15.75
- AVG Volume (30 Days)
- XPEL 141.6K
- VALN 132.0K
- Earning Date
- XPEL 11-06-2025
- VALN 11-06-2025
- Dividend Yield
- XPEL N/A
- VALN N/A
- EPS Growth
- XPEL 2.75
- VALN N/A
- EPS
- XPEL 1.76
- VALN N/A
- Revenue
- XPEL $448,897,000.00
- VALN $230,566,060.00
- Revenue This Year
- XPEL $12.54
- VALN $15.55
- Revenue Next Year
- XPEL $10.52
- VALN $23.93
- P/E Ratio
- XPEL $20.44
- VALN N/A
- Revenue Growth
- XPEL 9.96
- VALN 25.47
- 52 Week Low
- XPEL $24.25
- VALN $3.62
- 52 Week High
- XPEL $47.23
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- XPEL 47.55
- VALN 51.58
- Support Level
- XPEL $35.69
- VALN $8.33
- Resistance Level
- XPEL $39.21
- VALN $9.46
- Average True Range (ATR)
- XPEL 1.39
- VALN 0.32
- MACD
- XPEL -0.20
- VALN -0.13
- Stochastic Oscillator
- XPEL 32.10
- VALN 75.81
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.